![The Asian Pacific Association for the Study of the Liver [APASL]](https://www.apasl.info/wp-apasl/wp-content/themes/apasl/images/header/img_apasl_logo.png){kind=logo}
Finite Treatment with NUCs
| URL | http://ic-hep.com/webcasts/apasl2017/tberg/ |
|---|---|
| Speaker | Thomas BERG, Leipzig |
Clinical Decision Making of NUCs Therapy in HBV Patients in 2016/2017
| URL | http://ic-hep.com/webcasts/apasl2017/sgee/ |
|---|---|
| Speaker | Seng-Gee LIM, Singapore |
Hepatitis C: What Next after the Discovery of DAAs
| URL | http://ic-hep.com/webcasts/apasl2017/jliang/ |
|---|---|
| Speaker | T. Jake LIANG, Bethesda |
Countries and Regions Waiting Approval for DAAs – What is the Best Management Strategies?
| URL | http://ic-hep.com/webcasts/apasl2017/myu/ |
|---|---|
| Speaker | Ming-Lung YU, Kaohsiung |
Developing Countries and Regions – What Is the Role of Generic Drugs
| URL | http://ic-hep.com/webcasts/apasl2017/srahman/ |
|---|---|
| Speaker | Salimur RAHMAN, Dhaka |